Abbott Laboratories beat expectations with a quarterly profit thanks to strong medical device sales.
Sales of glucose monitoring products were particularly strong.
An increase in demand for medical interventions supported overall growth.
Annual earnings of 98 cents per share beat analysts' estimates by 3 cents.
Abbott Laboratories $ABT+0.5% raised its full-year forecast to $4.55 to… read more
Even if I only consider cars in the future, they were the first to deploy Gigapress. It was the cheapening of production that allowed them the highest margins initially. Nowadays almost everyone has them, well apart from VW they are content to snore there for now. That's where China has caught up and with government support has created significant competition. Tesla, however, is pulling out another ace Unboxed approach. I.e., another significant reduction in production costs. And there's no talk of putting Optimus into production yet, but it's a perfectly logical next step. After that, that is, if it succeeds, Tesla will certainly maintain its lead over its Chinese competitors in car production.